Clinical trials: COVID19 Patients
Chronic Obstructive Pulmonary Disease
Effect of Home Exercise Activity on Cortisol and Depression in COPD During the Pandemic COVID
exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the…
- Trial name
- NCT04639349
- Testing
- exercise group, control group
- Where
- Egypt
- Volunteers
- 40 people
- Sponsor
- Cairo University
Covid19, ARDS
Expanded Access for Use of bmMSC-Derived Extracellular Vesicles in Patients With COVID-19 Associated ARDS
ExoFlo, Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Allograft Product, Infusion Treatment is currently being studied in Protocol DB-EF-PhaseIII-0001 in patients COVID-19 associated moderate to severe acute…
- Conditions
- Covid19, ARDS, Hypoxia, Cytokine Storm
- Trial name
- NCT04657458
- Testing
- ExoFlo
- Sponsor
- Direct Biologics, LLC
Post-COVID19
Automatic Oxygen Titration in Patients After SARS-CoV-2 Infection
With the progression of the SARS-CoV-2 pandemic there's an increasing number of patients recovering from COVID19. Some of these patients still experience hypoxemia and therefore are still in need of a long-term oxygen therapy…
- Trial name
- NCT04849598
- Testing
- Oxygen therapy
- Where
- Germany
- Volunteers
- 15 people
- Sponsor
- Schön Klinik Berchtesgadener Land
Covid19, Pneumonia, Viral
Nebulized Heparin for the Treatment of COVID-19
Randomized, placebo controlled study to determine if nebulized heparin may reduce the need for mechanical ventilation in hospitalized patients with the novel coronavirus, also known as COVID-19.
- Trial name
- INHALE-HEP (NCT04723563)
- Testing
- Heparin, 0.9%sodium chloride
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Frederick Health
Post-COVID-19 Condition, Post-COVID Condition
Expanded Access Use of Human Umbilical Cord Blood (REGENECYTE) Infusion in Patients With Chronic Fatigue of Post-COVID Condition
REGENECYTE® (HPC, Cord Blood (Hematopoietic Progenitor Cell, Cord Blood)) for treatment in patients with post-COVID.
- Conditions
- Post-COVID-19 Condition, Post-COVID Condition, Post-COVID Syndrome, Long COVID
- Trial name
- NCT07332338
- Testing
- REGENECYTE®
- Where
- 2 sites in United States
- Sponsor
- StemCyte, Inc.
Post COVID-19 Condition (PCC), Dysfunctional Breathing
Dysfunctional Breathing in Post COVID-19 Condition.
The goal of this observational study with a cross-sectional design is to investigate what signs, symptoms and assessment which can describe and explain dysfunctional breathing in patients with post COVID-19 condition.
- Conditions
- Post COVID-19 Condition (PCC), Dysfunctional Breathing, Breathing Pattern Disorder, Post-Acute COVID-19 Syndrome
- Trial name
- DB-PCC (NCT06776263)
- Where
- 2 sites in Sweden
- Volunteers
- 200 people
- Sponsor
- Karolinska Institutet
COVID-19
Hyperimmune Plasma for Critical Patients With COVID-19
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become pandemic. To date, no specific treatment has been proven to be effective.
- Trial name
- COV19-PLASMA (NCT04321421)
- Testing
- hyperimmune plasma
- Where
- 2 sites in Italy
- Volunteers
- 49 people
- Sponsor
- Fondazione IRCCS Policlinico San Matteo di Pavia
Covid19, SARS-CoV-2 Infection
Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients
Non-commercial depersonalized multi-centered registry study on analysis of chronic non-infectious diseases dynamics after SARS-CoV-2 infection in adults.
- Conditions
- Covid19, SARS-CoV-2 Infection, Pneumonia, Copd
- Trial name
- ACTIV (NCT04492384)
- Testing
- non-interventional
- Where
- Russia
- Volunteers
- 6,396 people
- Sponsor
- Eurasian Association of Therapists
COVID-19
Long-term Outcomes in Patients With COVID-19
Long-term outcomes from coronavirus disease 2019 (COVID-19) are currently unknown. This study will collect daily living status of survivors of COVID-19.
- Trial name
- NCT04508712
- Where
- China
- Volunteers
- 900 people
- Sponsor
- RenJi Hospital
Covid19
Effect of Dalcetrapib in Patients With Confirmed Mild to Moderate COVID-19
This study is a placebo-controlled, Phase 2a proof-of-concept clinical study which will evaluate efficacy and safety of dalcetrapib in outpatients patients with mild to moderate, symptomatic, confirmed COVID 19.
- Trial name
- NCT04676867
- Testing
- Dalcetrapib
- Where
- Canada
- Volunteers
- 227 people
- Sponsor
- DalCor Pharmaceuticals
COVID
Detection of COVID-19 (SARS-CoV-2) in the Semen of COVID+ Patients (Positive RT-PCR on a Nasopharyngeal Swab)
The objective of this study is to look for the presence of SARS-CoV-2 in the semen of patients diagnosed with COVID+ based on RT-PCR analysis of nasopharyngeal swabs.
- Trial name
- COVISPERM (NCT04460534)
- Testing
- diagnostic
- Where
- France
- Volunteers
- 52 people
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche
COVID-19, Hydroxychloroquine Sulfate
Hydroxychloroquine for COVID-19
The current outbreak of COVID-19 caused by SARS-CoV-2 is a global health emergency with a case fatality rate so far approximately 4% and a growing number of confirmed cases (>9500) in Germany.
- Trial name
- COV-HCQ (NCT04342221)
- Testing
- Hydroxychloroquine Sulfate
- Where
- 8 sites in Germany
- Volunteers
- 30 people
- Sponsor
- University Hospital Tuebingen
COVID-19 Pneumonia, Thrombosis
Practice Variation on Antithrombotics in COVID-19
Evidence suggests coronavirus disease 2019 (COVID-19) is associated with an increased incidence of thromboembolic manifestations.
- Conditions
- COVID-19 Pneumonia, Thrombosis, COVID-19 Acute Respiratory Distress Syndrome, Severe Acute Respiratory Syndrome (SARS) Pneumonia
- Trial name
- NCT04998799
- Testing
- Current clinical practices of participating physicians
- Where
- India
- Volunteers
- 435 people
- Sponsor
- NMC Specialty Hospital
COVID-19
A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19.
This study aims to analyze the efficacy and safety of passive immunotherapy by administering an equine hyperimmune serum (INM005) against the SARS-CoV-2 receptor binding domain (RBD) to COVID-19 patients.
- Trial name
- NCT04494984
- Testing
- INM005
- Where
- 19 sites in Argentina
- Volunteers
- 243 people
- Sponsor
- Inmunova S.A.
Covid19
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
This study will be conducted as a registry to identify asymptomatic or symptomatic persons to determine whether they carry SARS-CoV-2 antibodies.
- Trial name
- NCT04352764
- Testing
- CoronaCideTM COVID-19 IgM/IgG Rapid Test and Premier Biotech COVID-19 IgM/IgG Rapid Test
- Where
- United States
- Volunteers
- 5,000 people, healthy volunteers welcome
- Sponsor
- Texas Cardiac Arrhythmia Research Foundation
Health Education, COVID-19, Quarantine, Anxiety, Pandemic
The Effectiveness of a Health Education Intervention to Reduce Anxiety in Quarantined COVID-19 Patients
we aimed to assess the impact of health education on the anxiety level of COVID-19 patients during the isolation period.
- Trial name
- NCT05715593
- Testing
- health education intervention
- Where
- Tunisia
- Volunteers
- 402 people
- Sponsor
- University of Monastir
COVID-19
Thorax Computed Tomography Severity Score and Outcome in COVID-19 Patients
The most common thorax Computed tomography (CT) findings are multifocal ground-glass opacities and peripheral consolidation in patients with COVID-19.
- Trial name
- NCT04424849
- Testing
- CT-Scan
- Where
- Turkey (Türkiye)
- Volunteers
- 40 people
- Sponsor
- Tepecik Training and Research Hospital
Multiple Sclerosis
Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication
The primary objective is to determine whether the use of immunomodulating medications have an impact on the ability to mount and sustain an immune response to SARS-CoV-2 spike protein following mRNA vaccination in patients with…
- Trial name
- NCT04796584
- Testing
- Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus
- Where
- United States
- Volunteers
- 20 people
- Sponsor
- Providence Health & Services
Infection Viral, Coronavirus
Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient
There is no predictive tool for patients admitted to the emergency department with a suspicion of Covid-19 that will worsen secondarily and require a heavy lifting.
- Conditions
- Infection Viral, Coronavirus, COVID-19
- Trial name
- BIOCOVU (NCT04341792)
- Where
- France
- Volunteers
- 373 people
- Sponsor
- University Hospital, Lille
COVID-19, Post-Acute COVID-19 Syndrome
Study on Post-Acute COVID-19 Syndrome in Improvement of COVID-19 Rehabilitated Patients by Respiratory Training
Since the emergence of Corona Virus Disease 2019(COVID-19), it has spread rapidly around the world, And it has had a profound impact on the lives and health of people around the world, most of the COVID-19 positive patients are…
- Conditions
- COVID-19, Post-Acute COVID-19 Syndrome, Dyspnea, Incentive Spirometer
- Trial name
- NCT06165835
- Testing
- breathing training
- Where
- Taiwan
- Volunteers
- 90 people, healthy volunteers welcome
- Sponsor
- Tri-Service General Hospital (TSGH)
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.